These results suggest that transcriptome alterations are usually distinct in iMNs derived from patients with ALS with mutations in C9orf72, FUS, TARDBP, or SOD1 but may overlap to some extent in mature iMNs with perturbed electrophysiological properties. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.